| Product Name |
Code |
Size |
| Recombinant Human Intestinal-type alkaline phosphatase (ALPI) (Active) |
CSB-MP001627HU |
1mg/100ug/20ug |
| Recombinant Human Angiopoietin-2 (ANGPT2) (Active) |
CSB-MP001707HU(A4) |
1mg/100ug/20ug |
| Recombinant Human C-X-C chemokine receptor type 4 (CXCR4)-VLPs (Active) |
CSB-MP006254HU(F1) |
1mg/100ug/20ug |
| Recombinant Human Tissue factor pathway inhibitor (TFPI), partial (Active) |
CSB-MP023437HU |
1mg/100ug/20ug |
| Recombinant Human Melanoma-associated antigen 4 (MAGEA4) (Active) |
CSB-MP013330HU |
1mg/100ug/20ug |
| Recombinant Human R-spondin-1 (RSPO1), partial (Active) |
CSB-MP644834HU1 |
1mg/100ug/20ug |
| Recombinant Mouse Microtubule-associated protein tau (Mapt) (Active) |
CSB-MP013481MO |
1mg/100ug/20ug |
| Recombinant Macaca mulatta Microtubule-associated protein tau (MAPT) (Active) |
CSB-MP013481MOW |
1mg/100ug/20ug |
| Recombinant Human Claudin-3 (CLDN3)-VLPs (Active) |
CSB-MP005505HU |
1mg/100ug/20ug |
| Recombinant Human G-protein coupled receptor family C group 5 member D (GPRC5D)-VLPs (Active) |
CSB-MP882153HU |
1mg/100ug/20ug |
| Recombinant Human Endothelin-1 receptor (EDNRA)-VLPs (Active) |
CSB-MP007403HU |
1mg/100ug/20ug |
| Recombinant Human Leukocyte antigen CD37 (CD37)-VLPs (Active) |
CSB-MP004928HU |
1mg/100ug/20ug |
| Recombinant Human C-C chemokine receptor type 6(CCR6)-VLPs (Active) |
CSB-MP004845HU |
1mg/100ug/20ug |
| Recombinant Human C-C chemokine receptor type 5 (CCR5)-VLPs (Active) |
CSB-MP004844HU |
1mg/100ug/20ug |
| Recombinant Human C-C chemokine receptor type 4 (CCR4)-VLPs (Active) |
CSB-MP004843HU |
1mg/100ug/20ug |
| Recombinant Human Prolactin receptor (PRLR), partial (Active) |
CSB-MP018727HU1d7 |
1mg/100ug/20ug |
| Recombinant Human C5a anaphylatoxin chemotactic receptor 1 (C5AR1)-VLPs (Active) |
CSB-MP003996HU |
1mg/100ug/20ug |
| Recombinant Human E3 ubiquitin-protein ligase ZNRF3 (ZNRF3), partial (Active) |
CSB-MP890933HU |
1mg/100ug/20ug |
| Recombinant Mouse Prolactin receptor (Prlr), partial (Active) |
CSB-MP018727MO |
1mg/100ug/20ug |
| Recombinant Human IGF-like family receptor 1 (IGFLR1), partial (Active) |
CSB-MP862025HU |
1mg/100ug/20ug |
| Recombinant Human IGF-like family receptor 1 (IGFLR1), partial (Active) |
CSB-MP862025HUd9 |
1mg/100ug/20ug |
| Recombinant Human HLA class II histocompatibility antigen gamma chain (CD74), partial (Active) |
CSB-MP004956HU1(F2) |
1mg/100ug/20ug |
| Recombinant Human T-cell surface protein tactile (CD96), partial (Active) |
CSB-MP004971HU1(F2) |
1mg/100ug/20ug |
| Recombinant Human Cytokine receptor common subunit beta (CSF2RB), partial (Active) |
CSB-MP006047HU |
1mg/100ug/20ug |
| Recombinant Human Poliovirus receptor (PVR) (I340M), partial (Active) |
CSB-MP019093HU(M) |
1mg/100ug/20ug |
| Recombinant Human Signal transducer CD24 (CD24)-Nanoparticle (Active) |
CSB-MP004902HU |
1mg/100ug/20ug |
| Recombinant Human C-C chemokine receptor type 8 (CCR8)-VLPs (Active) |
CSB-MP004847HU |
1mg/100ug/20ug |
| Recombinant Human Nectin-4 (NECTIN4), partial (Active) |
CSB-MP822274HU |
1mg/100ug/20ug |
| Recombinant Human Insulin growth factor-like family member 1 (IGFL1) (Active) |
CSB-MP764932HU |
1mg/100ug/20ug |
| Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), partial (Active) |
CSB-MP023984HU1 |
1mg/100ug/20ug |
| Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active) |
CSB-MP023997HU1 |
1mg/100ug/20ug |
| Recombinant Human Tyrosine-protein kinase Mer (MERTK), partial (Active) |
CSB-MP621519HU |
1mg/100ug/20ug |
| Recombinant Human Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1), partial (Active) |
CSB-MP020067HU1d7 |
1mg/100ug/20ug |
| Recombinant Human Plexin-B1 (PLXNB1), partial (Active) |
CSB-MP018222HU2k6 |
1mg/100ug/20ug |
| Recombinant Human B-lymphocyte antigen CD20 (MS4A1)-VLPs (Active) |
CSB-MP015007HU |
1mg/100ug/20ug |
| Recombinant Human papillomavirus type 16 Protein E7 (E7) (Active) |
CSB-EP365855HMLg5 |
1mg/100ug/20ug |
| Recombinant Mouse Desmoglein-3 (Dsg3), partial (Active) |
CSB-MP007205MOd7 |
1mg/100ug/20ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (S202N) (Active) |
CSB-EP3325GMY(M8) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (D63G,R203M,D377Y) (Active) |
CSB-EP3325GMY(M14) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (R203M,D377Y) (Active) |
CSB-EP3325GMY(M13) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (D3L,R203K,G204R,S235F) (Active) |
CSB-EP3325GMY(M1) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (R203K,G204R) (Active) |
CSB-EP3325GMY(M12) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (Q384H) (Active) |
CSB-EP3325GMY(M11) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (I292T) (Active) |
CSB-EP3325GMY(M10) |
1mg(1mg*1 or 500ug*2)/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (L230F) (Active) |
CSB-EP3325GMY(M9) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (D103Y) (Active) |
CSB-EP3325GMY(M5) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (P13L) (Active) |
CSB-EP3325GMY(M4) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (P80R) (Active) |
CSB-EP3325GMY(M3) |
1mg/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (T205I) (Active) |
CSB-EP3325GMY(M2) |
1mg/100ug |
| Recombinant Human Claudin-18.2 (CLDN18.2)-VLPs (Active) |
CSB-MP005498HU(A5) |
1mg/100ug/20ug |
